Brethine Subcutaneous and Cisatracurium besylate Intravenous
Determining the interaction of Brethine Subcutaneous and Cisatracurium besylate Intravenous and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Terbutaline may increase the effects of cisatracurium, which may result in a higher risk of respiratory depression and muscle weakness. Talk to your doctor if you have any concerns. You should be closely monitored by the doctor during the procedure, and the dosages adjusted as necessary. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Some drugs may enhance the effects of neuromuscular blocking agents.
MANAGEMENT: Observation for profound and prolonged respiratory depression and muscle weakness is recommended if these drugs must be used together.
- "Product Information. Anectine (succinylcholine)." Glaxo Wellcome, Research Triangle Park, NC.
- "Multum Information Services, Inc. Expert Review Panel"
Generic Name: terbutaline
Brand name: Brethine
Synonyms: Brethine
Generic Name: cisatracurium
Brand name: Nimbex
Synonyms: Cisatracurium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brethine Subcutaneous-Cisplatin
- Brethine Subcutaneous-Cisplatin Intravenous
- Brethine Subcutaneous-Citalopram
- Brethine Subcutaneous-Citalopram Capsules
- Brethine Subcutaneous-Citalopram Hydrobromide
- Brethine Subcutaneous-Citalopram Oral Solution
- Cisatracurium besylate Intravenous-Bretylium
- Cisatracurium besylate Intravenous-Bretylium Injection
- Cisatracurium besylate Intravenous-Brevibloc
- Cisatracurium besylate Intravenous-Brevibloc in NaCl
- Cisatracurium besylate Intravenous-Brevibloc Premixed
- Cisatracurium besylate Intravenous-Brevibloc Premixed DS